Explore the categories so you can find more about your search.

Categorie > Lupus

Categorie : Lupus
The genetic cause of Job's Syndrome -- a rare disorder of the immune system and connective tissue -- has been identified by U.S. researchers. ...

read more The genetic cause of Job's Syndrome -- a rare disorder of the immune system and connective tissue -- has been identified by U.S. researchers. read more Sun Oct 2007 Sun Oct 2007

Categorie : Lupus
Two genes boost the risk of painful rheumatoid arthritis, and one of them also increases the odds for lupus, according to two new reports. ...

read more Two genes boost the risk of painful rheumatoid arthritis, and one of them also increases the odds for lupus, according to two new reports. read more Sun Oct 2007 Sun Oct 2007

Categorie : Lupus
Even when they appear clinically similar, patients with potentially deadly sepsis may be having different kinds of immune responses, say U.S. researchers who conducted the first large-scale natural history study of the common condition. ...

read more Even when they appear clinically similar, patients with potentially deadly sepsis may be having different kinds of immune responses, say U.S. researchers who conducted the first large-scale natural history study of the common condition. read more Sun Oct 2007 Sun Oct 2007

Categorie : Lupus
Thanks to an increasingly complex coverage system, many U.S. kids who are privately insured are actually having more trouble getting recommended vaccines than kids who have no insurance at all, experts say. ...

read more Thanks to an increasingly complex coverage system, many U.S. kids who are privately insured are actually having more trouble getting recommended vaccines than kids who have no insurance at all, experts say. read more Sun Oct 2007 Sun Oct 2007

Categorie : Lupus
The common scientific wisdom on how HIV infection proceeds to full-blown AIDS might be wrong, two U.S. researchers say. ...

read more The common scientific wisdom on how HIV infection proceeds to full-blown AIDS might be wrong, two U.S. researchers say. read more Sun Oct 2007 Sun Oct 2007

Lupus Foundation Of America Statement On Results For Clinical Study Of CellCept(R) Released By Aspreva Pharmaceutical Company

Categorie : Lupus
The Lupus Foundation of America, Inc. and more than 1.5 million Americans with lupus have been awaiting the preliminary findings of the Phase III clinical trials for CellCept(R), a potential treatment for lupus kidney disease being tested by Aspreva Pharmaceutical Company. [click link for full arti ...

read more The Lupus Foundation of America, Inc. and more than 1.5 million Americans with lupus have been awaiting the preliminary findings of the Phase III clinical trials for CellCept(R), a potential treatment for lupus kidney disease being tested by Aspreva Pharmaceutical Company. [click link for full arti read more Sun Oct 2007 Sun Oct 2007

Treatment With Belimumab Showed Improvement In Symptoms In 46 Percent Of Lupus Patients At 52 Weeks

Categorie : Lupus
Treatment with belimumab resulted in a sustained improvement of systemic lupus erythematosus (SLE or lupus) disease activity in 46% of patients at week 52, according to a novel combined responder index in results presented at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spa ...

read more Treatment with belimumab resulted in a sustained improvement of systemic lupus erythematosus (SLE or lupus) disease activity in 46% of patients at week 52, according to a novel combined responder index in results presented at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spa read more Sun Oct 2007 Sun Oct 2007

At Long Term Follow-Up Over OneThird Of Refractory Lupus Patients Remain Stable

Categorie : Lupus
36% of patients with refractory systemic lupus erythematosus (SLE or lupus) remain well after undergoing B-cell depletion therapy (BCDT) without needing further standard immunosuppressive agents, according to a study presented at EULAR 2007, the Annual European Congress of Rheumatology in Barcel ...

read more 36% of patients with refractory systemic lupus erythematosus (SLE or lupus) remain well after undergoing B-cell depletion therapy (BCDT) without needing further standard immunosuppressive agents, according to a study presented at EULAR 2007, the Annual European Congress of Rheumatology in Barcel read more Sun Oct 2007 Sun Oct 2007

MedImmune Advances Potential Treatment For Patients With Lupus

Categorie : Lupus
MedImmune, Inc. today announced that it has begun dosing patients in a multi-dose, Phase 1b clinical trial with its monoclonal antibody (MAb) targeting interferon-alpha, known as MEDI-545. The study is designed to evaluate the safety and tolerability of multiple doses of the MAb in pati ...

read more MedImmune, Inc. today announced that it has begun dosing patients in a multi-dose, Phase 1b clinical trial with its monoclonal antibody (MAb) targeting interferon-alpha, known as MEDI-545. The study is designed to evaluate the safety and tolerability of multiple doses of the MAb in pati read more Sun Oct 2007 Sun Oct 2007

Medarex Announces Advancement Of Antibody Development By Partner

Categorie : Lupus
Medarex, Inc. (Nasdaq: MEDX) announced today that its partner MedImmune, Inc. has initiated a Phase Ib multi-dose clinical trial of MEDI-545 for the potential treatment of systemic lupus erythematosus (SLE or lupus). MEDI-545 is a fully human antibody generated by Medarex's UltiMAb Huma ...

read more Medarex, Inc. (Nasdaq: MEDX) announced today that its partner MedImmune, Inc. has initiated a Phase Ib multi-dose clinical trial of MEDI-545 for the potential treatment of systemic lupus erythematosus (SLE or lupus). MEDI-545 is a fully human antibody generated by Medarex's UltiMAb Huma read more Sun Oct 2007 Sun Oct 2007

Preliminary Results For Phase III Study Evaluating CellCept In Lupus Nephritis

Categorie : Lupus
Aspreva Pharmaceuticals Corporation and Roche today released preliminary results for a clinical phase III trial comparing CellCept (oral mycophenolate mofetil, MMF) to intravenous cyclophosphamide (IVC), which is the current standard of care, for inducing treatment response in the induction phase of ...

read more Aspreva Pharmaceuticals Corporation and Roche today released preliminary results for a clinical phase III trial comparing CellCept (oral mycophenolate mofetil, MMF) to intravenous cyclophosphamide (IVC), which is the current standard of care, for inducing treatment response in the induction phase of read more Sun Oct 2007 Sun Oct 2007

Lupus Foundation Of America Issues A Call For Nominations For The 2007 Evelyn V. Hess Award

Categorie : Lupus
Evelyn V. Hess, M.D., MACP, MACR, is an internationally known expert in lupus, with a special interest in the area of the environmental aspects of lupus. In recognition of her outstanding contributions to lupus research over the course of her long career, the Lupus Foundation of America, Inc. (LFA) ...

read more Evelyn V. Hess, M.D., MACP, MACR, is an internationally known expert in lupus, with a special interest in the area of the environmental aspects of lupus. In recognition of her outstanding contributions to lupus research over the course of her long career, the Lupus Foundation of America, Inc. (LFA) read more Sun Oct 2007 Sun Oct 2007

New Research May Predict Who Is At Risk To Develop Lupus

Categorie : Lupus
Certain families produce higher levels of a specific molecule, called interferon-alpha, that primes the body's immune system to turn on, and in some cases initiate an autoimmune attack on itself, according to new research from Hospital for Special Surgery in New York City. Our immune system is a ...

read more Certain families produce higher levels of a specific molecule, called interferon-alpha, that primes the body's immune system to turn on, and in some cases initiate an autoimmune attack on itself, according to new research from Hospital for Special Surgery in New York City. Our immune system is a read more Sun Oct 2007 Sun Oct 2007

Lupus Foundation of America Announces 2007 Gina Finzi Memorial Student Summer Fellowship Recipients

Categorie : Lupus
The Lupus Foundation of America (LFA), the nation's leading nonprofit health organization dedicated to finding the causes and cure for lupus, is proud to announce the winners of this year's Gina Finzi Memorial Student Summer Fellowship. The LFA has awarded the five summer fellowships as part of the ...

read more The Lupus Foundation of America (LFA), the nation's leading nonprofit health organization dedicated to finding the causes and cure for lupus, is proud to announce the winners of this year's Gina Finzi Memorial Student Summer Fellowship. The LFA has awarded the five summer fellowships as part of the read more Sun Oct 2007 Sun Oct 2007

Lupus And Genetic Mutations Linked By Research

Categorie : Lupus
A gene discovered by scientists at Wake Forest University School of Medicine has been linked to lupus and related autoimmune diseases. The finding, reported in the current issue of Nature Genetics, is the latest in a series of revelations that shed new light on what goes wrong in human cells to caus ...

read more A gene discovered by scientists at Wake Forest University School of Medicine has been linked to lupus and related autoimmune diseases. The finding, reported in the current issue of Nature Genetics, is the latest in a series of revelations that shed new light on what goes wrong in human cells to caus read more Sun Oct 2007 Sun Oct 2007

Genetic Cause Discovered For Systemic Lupus Erythematosus

Categorie : Lupus
Mutations in a gene researchers call TREX1 is one cause for systemic lupus erythematosus (SLE), a severe and incurable autoimmune disease. This is the result of a new study headed by Professor Norbert Hubner from the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch and Dr. ...

read more Mutations in a gene researchers call TREX1 is one cause for systemic lupus erythematosus (SLE), a severe and incurable autoimmune disease. This is the result of a new study headed by Professor Norbert Hubner from the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch and Dr. read more Sun Oct 2007 Sun Oct 2007

Have We Uncovered A New Form Of Lupus?

Categorie : Lupus
Findings published online in the prestigious Journal of Experimental Medicine may offer new hope to people suffering from a previously unsuspected form of lupus. [click link for full article] ...

read more Findings published online in the prestigious Journal of Experimental Medicine may offer new hope to people suffering from a previously unsuspected form of lupus. [click link for full article] read more Sun Oct 2007 Sun Oct 2007

Lupus Patients May Benefit From Organ-Transplant Rejection Drug

Categorie : Lupus
A compound related to a drug used in humans to prevent organ-transplant rejection attacks a key biochemical process in the faulty immune cells of lupus-prone mice, suggesting a possible new approach to combating the disease, UT Southwestern Medical Center researchers have found."We found tha ...

read more A compound related to a drug used in humans to prevent organ-transplant rejection attacks a key biochemical process in the faulty immune cells of lupus-prone mice, suggesting a possible new approach to combating the disease, UT Southwestern Medical Center researchers have found. read more Sun Oct 2007 Sun Oct 2007

ZymoGenetics And Merck Serono Receive FDA Special Protocol Assessment For Atacicept Pivotal Study In Lupus Nephritis

Categorie : Lupus
ZymoGenetics, Inc. (Nasdaq: ZGEN) announced that, together with its collaborator Merck Serono, it has reached agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) to conduct a pivotal clinical trial with the investigational new drug atacicept for the tre ...

read more ZymoGenetics, Inc. (Nasdaq: ZGEN) announced that, together with its collaborator Merck Serono, it has reached agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) to conduct a pivotal clinical trial with the investigational new drug atacicept for the tre read more Sun Oct 2007 Sun Oct 2007

Clinical Trials For Lupus Underway After Decades Of Drought

Categorie : Lupus
For the first time in decades, a significant number of clinical trials are being conducted to seek a treatment, perhaps even a cure, for lupus, a chronic and potentially fatal autoimmune disease that affects more than 1.5 million Americans -- 10,000 in Los Angeles County alone. [click link ...

read more For the first time in decades, a significant number of clinical trials are being conducted to seek a treatment, perhaps even a cure, for lupus, a chronic and potentially fatal autoimmune disease that affects more than 1.5 million Americans -- 10,000 in Los Angeles County alone. [click link read more Sun Oct 2007 Sun Oct 2007

1 | 2 | 3 | 4 next >>>



     


Custom Search